AFFYMETRIX JETZT KAUFEN!!! NACHBÖRSLICH GUTE NEWS!!!!! - 500 Beiträge pro Seite

[veco]

Affymetrix and OGT Settle Litigation
SANTA CLARA, Calif., March 23 /PRNewswire/ -- Affymetrix, Inc., (Nasdaq: AFFX - news) and Oxford Gene Technology, Ltd. (OGT) today announced the settlement of all existing litigation between the two companies. Financial details were not disclosed.

The settlement encompasses a number of lawsuits. Key components of the settlement include:


-- OGT and Affymetrix will dismiss the pending lawsuits in the Delaware
Federal Court.

-- OGT will drop its infringement actions and both parties will drop their
revocation actions challenging each others` patents in the
United Kingdom.

-- OGT will withdraw their petition for leave to appeal to the House of
Lords in the license action in the United Kingdom.

-- Both parties will cease their involvement in opposition proceedings
against the other`s European patent in the European Patent Office.


Professor Edwin Southern, majority owner and Chairman of OGT, said ``It is essential for genomic research that these matters have been resolved and that OGT can concentrate on its main objectives of developing its own technology and business and licensing others to do the same.``

``All of us at Affymetrix prefer to focus our energies on providing state of the art genetic analysis tools to help our customers achieve cutting-edge results,`` said Susan E. Siegel, President of Affymetrix. ``We are delighted to have these matters behind us.``

Affymetrix is a leader in developing and commercializing systems to acquire, analyze and manage complex genetic information in order to improve the quality of life. The Company`s GeneChip® system consists of disposable DNA probe arrays containing gene sequences on a chip, reagents for use with the probe arrays, a scanner, and other instruments to process the probe arrays and software to analyze and manage genetic information. The Company`s spotted array system enables individual researchers to create and analyze custom microarrays on an easy-to-use, cost efficient platform. Additional information on Affymetrix and GeneChip technology can be found at www.affymetrix.com.

All statements in this press release that are not historical are ``forward-looking statements`` within the meaning of Section 21E of the Securities Exchange Act as amended, including statements regarding Affymetrix` ``expectations,`` ``beliefs,`` ``hopes,`` ``intentions,`` ``strategies`` or the like. Such statements are subject to risks and uncertainties that could cause actual results to differ materially for Affymetrix from those projected, including, but not limited to, uncertainties relating to technological approaches, product development, manufacturing, market acceptance, personnel retention, equity dilution, uncertainties related to the ability to realize benefits from acquisitions, uncertainties related to cost and pricing of Affymetrix products, dependence on collaborative partners, uncertainties relating to sole source suppliers, uncertainties relating to FDA and other regulatory approvals, competition, risks relating to intellectual property of others and the uncertainties of patent protection and litigation. These and other risk factors are discussed in Affymetrix` Annual Report on Form 10-K for the year ended December 31, 1999 and other SEC reports, including its Quarterly Reports on Form 10-Q for subsequent quarterly periods. Affymetrix expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in Affymetrix` expectations with regard thereto or any change in events, conditions, or circumstances on which any such statements are based.

NOTE: Affymetrix, GeneChip and the Affymetrix logo are registered trademarks used by Affymetrix, Inc.

SOURCE: Affymetrix, Inc.

[giggas]

Kann mir jemand die obige meldung kurz zusammenfassen,wäre sehr dankbar.

[bigtime]

Ein Rechtsstreit wurde beigelegt. Somit haben die Anleger mehr Sicherheit mit AFFX.




Mfg bigtime